Dosing of Convalescent Plasma and Hyperimmune Anti-SARS-CoV-2 Immunoglobulins: A Phase I/II Dose-Finding Study.
Sammy HuygensTim PreijersFrancis H SwaneveldIlona Kleine BuddeCorine H Geurts van KesselBirgit C P KochBart J A RijndersPublished in: Clinical pharmacokinetics (2024)
NL9379 (The Netherlands Trial Register).